A detailed history of Jane Street Group, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 649,960 shares of CRBU stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
649,960
Previous 668,500 2.77%
Holding current value
$1.27 Million
Previous $1.1 Million 15.6%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.56 - $2.73 $28,922 - $50,614
-18,540 Reduced 2.77%
649,960 $1.27 Million
Q2 2024

Aug 14, 2024

BUY
$1.62 - $5.05 $983,795 - $3.07 Million
607,281 Added 991.98%
668,500 $1.1 Million
Q1 2024

May 15, 2024

SELL
$4.82 - $8.26 $256,009 - $438,721
-53,114 Reduced 46.46%
61,219 $314,000
Q4 2023

Feb 14, 2024

BUY
$3.58 - $6.25 $237,167 - $414,050
66,248 Added 137.77%
114,333 $655,000
Q3 2023

Nov 14, 2023

SELL
$4.08 - $8.14 $506,858 - $1.01 Million
-124,230 Reduced 72.09%
48,085 $229,000
Q2 2023

Aug 14, 2023

BUY
$4.04 - $5.47 $696,152 - $942,563
172,315 New
172,315 $732,000
Q3 2022

Nov 14, 2022

BUY
$5.34 - $12.79 $92,451 - $221,433
17,313 New
17,313 $183,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $119M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.